{"id":"CHEMBL1075733","canonicalSmiles":"CCC(C)C(CC)C(N)=O","inchiKey":"QRCJOCOSPZMDJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALNOCTAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Axiquel"],"synonyms":["MCN-X-181","NSC-32363","NSC-34092","Valnoctamide"],"crossReferences":{"Wikipedia":["Valnoctamide"],"drugbank":["DB13099"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1078033","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O.[Na+]","inchiKey":"KLOHDWPABZXLGI-YWUHCJSESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1078033","maximumClinicalTrialPhase":0,"parentId":"CHEMBL174","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1079604","canonicalSmiles":"Cc1cc(C)cc(OCC2CNC(=O)O2)c1","inchiKey":"IMWZZHHPURKASS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METAXALONE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metaxalone","Skelaxin"],"synonyms":["AHR-438","Metaxalone","NSC-170959"],"crossReferences":{"DailyMed":["metaxalone"],"PubChem":["144204981","170465241","26748938"],"Wikipedia":["Metaxalone"],"drugbank":["DB00660"],"chEBI":["6797"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL1128","canonicalSmiles":"CC[N+](C)(C)c1cccc(O)c1.[Cl-]","inchiKey":"BXKDSDJJOVIHMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDROPHONIUM CHLORIDE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1104","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Camsilon","Edrophonium chloride","Edrophonium chloride preservative free","Enlon","Reversol","Tensilon","Tensilon preservative free"],"synonyms":["Edrophone chloride","Edrophonium Chloride","Edrophonium chloride"],"crossReferences":{"PubChem":["144203689","170464801","26747508","26747509","50106293","50106294","50106295","56422101","855983"],"Wikipedia":["Edrophonium"],"chEBI":["4759"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1951."}
{"id":"CHEMBL1134","canonicalSmiles":"C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C.[Br-].[Br-]","inchiKey":"HLXQFVXURMXRPU-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"DECAMETHONIUM BROMIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1190","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Syncurine"],"synonyms":["Decamethonium Bromide","Decamethonium bromide","Decamethonium iodide"],"crossReferences":{"PubChem":["144205588","170465349","50106154","855712"],"Wikipedia":["Decamethonium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL115","canonicalSmiles":"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O","inchiKey":"CBVCZFGXHXORBI-PXQQMZJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDINAVIR","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crixivan"],"synonyms":["Crixivan","Indinavir","Indinavir monohydrate","Indinavir system suitability","L-735524","MK-639"],"crossReferences":{"DailyMed":["indinavir%20sulfate"],"PubChem":["29215411"],"drugbank":["DB00224"],"chEBI":["44032"]},"childChemblIds":["CHEMBL1735"],"count":4,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for viral disease and has 3 investigational indications."}
{"id":"CHEMBL118","canonicalSmiles":"Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1","inchiKey":"RZEKVGVHFLEQIL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CELECOXIB","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"year":2011},"tradeNames":["Celebra","Celebrex","Celecoxib","Elyxyb","Onsenal"],"synonyms":["Celecoxib","DFN-15","DFN15","SC-58635"],"crossReferences":{"DailyMed":["celecoxib"],"PubChem":["144204686","144209162","144210916","170464693","17389545","26747363","49665790","49666478","535138"],"Wikipedia":["Celecoxib"],"drugbank":["DB00482"],"chEBI":["41423"]},"childChemblIds":["CHEMBL395268","CHEMBL1801594"],"count":95,"approvedIndications":["EFO_0000616","EFO_0000685","EFO_0002506","Orphanet_733","EFO_0003898","HP_0100607","EFO_0003843","EFO_0005755","EFO_0002609","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_0000365","EFO_0000756","EFO_0000249","EFO_0000681","EFO_0003768","EFO_1001951","MONDO_0002974","EFO_0009582","MONDO_0008903","EFO_0004616","EFO_0001668","EFO_1001904","EFO_0004288","MONDO_0002715","EFO_0005762","EFO_0002618","HP_0012532","EFO_0010072","MONDO_0002363","MONDO_0042487","Orphanet_636","EFO_0004607","EFO_0000384","MONDO_0008315","EFO_0002496","MONDO_0002691","MP_0001914","EFO_0009260","EFO_0000546","HP_0100607","EFO_0001378","EFO_0007328","MONDO_0002258","EFO_0003767","MONDO_0018373","MONDO_0007254","EFO_0000284","EFO_0004252","MONDO_0044937","EFO_0009606","EFO_0000289","MONDO_0002050","EFO_0000326","EFO_1001893","MONDO_0002618","EFO_0009625","EFO_0000616","EFO_0006859","EFO_0001645","EFO_0003898","HP_0011110","MONDO_0007576","HP_0003418","EFO_0001073","EFO_0003843","EFO_0000537","EFO_0000199","MONDO_0024880","EFO_0000519","MONDO_0024475","EFO_0008525","EFO_0003869","EFO_0005543","EFO_0001075","MONDO_0002009","Orphanet_905","EFO_0005406","EFO_0004274","EFO_1000657","EFO_0004251","EFO_0002506","Orphanet_733","EFO_1000786","EFO_0000182","EFO_1001228","HP_0003419","EFO_0000253","EFO_0000692","EFO_1000166","EFO_1001250","EFO_0001416","EFO_0003893","MONDO_0004658","EFO_0003821","EFO_0004224","EFO_1001466","MONDO_0008170","Orphanet_3389","EFO_0002939","EFO_1002029","MP_0001845","EFO_0003868","EFO_0000731","EFO_0000668","MONDO_0021640","EFO_0007453","EFO_0005252","MONDO_0021063","MONDO_0002087","Orphanet_538","EFO_0000305","MONDO_0001187","HP_0004398","EFO_1001480","MONDO_0001657","EFO_0000673","EFO_0005279","EFO_0004242","EFO_0007490","EFO_1000158","EFO_0000685","EFO_0005755","EFO_0003060","EFO_0002609","EFO_0000311","EFO_0000621","EFO_0000203","EFO_0001072","EFO_0004142","EFO_0000706","EFO_0005611","EFO_0000691","EFO_1001950"],"count":123},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 10 approved and 85 investigational indications. It was withdrawn in European Union  in 2011. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200461","canonicalSmiles":"COc1ccc(OC)c(C(O)CNC(=O)CN)c1.Cl","inchiKey":"MGCQZNBCJBRZDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MIDODRINE HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201212","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bramox","Gutron","Midodrine hydrochloride","Midon","Orvaten","Proamatine"],"synonyms":["A-4020 LINZ","Midodrine hydrochloride","ST 1085 HYDROCHLORIDE","ST 1085 [AS THE BASE]","ST-1085","ST-1085 BASE","ST-1085 HYDROCHLORIDE","ST-PETER-224","ST. PETER 224"],"crossReferences":{"DailyMed":["midodrine%20hydrochloride"],"PubChem":["144204080","144213040","170464672","56320803"],"chEBI":["31847"]},"count":4,"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["HP_0100806","EFO_0006834","EFO_0000712","EFO_0005252","EFO_1001488"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200572","canonicalSmiles":"O=[Mg]","inchiKey":"CPLXHLVBOLITMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM OXIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mag ox","Mag-ox 400","Magdose","Magstar","Oromag 160","Oximag","Uro-mag"],"synonyms":["E-530","E530","INS NO.530","INS-530","Magnesium oxide","Magnesium oxide heavy"],"crossReferences":{"DailyMed":["magnesium%20oxide"],"Wikipedia":["Magnesium_oxide"]},"count":5,"approvedIndications":["HP_0002019","HP_0001891"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for iron deficiency anemia and constipation and has 3 investigational indications."}
{"id":"CHEMBL1200636","canonicalSmiles":"CN(C)CCC=C1c2ccccc2C=Cc2ccccc21.Cl","inchiKey":"VXEAYBOGHINOKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOBENZAPRINE HYDROCHLORIDE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL669","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amrix","Cyclobenzaprine hydrochloride","Flexeril"],"synonyms":["Cyclobenzaprine hydrochloride","MK-130","MK-130 HYDROCHLORIDE","MK-130 [AS THE BASE]","NSC-169900","NSC-173379","NSC-78206"],"crossReferences":{"DailyMed":["cyclobenzaprine%20hydrochloride"],"PubChem":["124891634","144203591","170464953","26748730","26748731","50106063","50107452","50107453","551139","56463037"],"chEBI":["3997"]},"count":5,"approvedIndications":["HP_0001257","HP_0003326","EFO_0009488","EFO_1000632"],"linkedTargets":{"rows":["ENSG00000102468","ENSG00000147246"],"count":2},"linkedDiseases":{"rows":["HP_0001257","HP_0003326","EFO_0003821","EFO_0009488","EFO_1000632"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 4 approved and 1 investigational indication."}
{"id":"CHEMBL1200722","canonicalSmiles":"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H](N3CC[N+](C)(C)CC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CC[N+](C)(C)CC1.[Br-].[Br-]","inchiKey":"TXWBOBJCRVVBJF-YTGGZNJNSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPECURONIUM BROMIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201206","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arduan"],"synonyms":["Pipecuronium bromide","RGH 1106","RGH-1106"],"crossReferences":{"Wikipedia":["Pipecuronium_bromide"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL1200728","canonicalSmiles":"Cl.N=C(N)N","inchiKey":"PJJJBBJSCAKJQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANIDINE HYDROCHLORIDE","yearOfFirstApproval":1939,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL821","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Guanidine hydrochloride"],"synonyms":["Guanidine HCl","Guanidine hydrochloride"],"crossReferences":{"DailyMed":["guanidine%20hydrochloride"],"chEBI":["32735"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1939."}
{"id":"CHEMBL1200930","canonicalSmiles":"COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[n-]2)c1C.[Na+]","inchiKey":"KRCQSTCYZUOBHN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RABEPRAZOLE SODIUM","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1219","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aciphex","Aciphex sprinkle","Pariet","Rabeprazole sodium"],"synonyms":["E-3810","E-3810 SODIUM","LY-307640","LY-307640 SODIUM","LY307640 SODIUM","Rabeprazole sodium","Rabeprazole sodium salt"],"crossReferences":{"DailyMed":["rabeprazole%20sodium"],"PubChem":["144205289","144212634","170464736","49666380"],"chEBI":["8769"]},"count":6,"approvedIndications":["EFO_0003948","EFO_0004607","EFO_0007549"],"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","EFO_0009454","EFO_0010282","EFO_0003763","EFO_0004607","EFO_1000961","EFO_0007549","EFO_1001355","EFO_1001095"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL1201049","canonicalSmiles":"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1.O=[N+]([O-])O","inchiKey":"DDXORDQKGIZAME-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ECONAZOLE NITRATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL808","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Econazole nitrate","Ecostatin","Ecostatin twin pack","Ecostatin-1","Ecoza","Gyno-pevaryl","Gyno-pevaryl 1 cp pack","Gyno-pevaryl 150","Gyno-pevaryl once","Pevaryl","Spectazole"],"synonyms":["Econazole nitrate","NSC-243115","R 14,827","R-14827","SQ 13050","SQ-13050"],"crossReferences":{"DailyMed":["econazole%20nitrate"],"PubChem":["144204403","144207969","144213703","170465422","17389020","26748545","56422230","568319","855519"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL1201216","canonicalSmiles":"Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1","inchiKey":"RFWZESUMWJKKRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPIPRAZOLE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dapiprazole"],"crossReferences":{"Wikipedia":["Dapiprazole"],"drugbank":["DB00298"],"chEBI":["51066"]},"childChemblIds":["CHEMBL1201044"],"count":1,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000120907"],"count":1},"linkedDiseases":{"rows":["EFO_0000516"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990 and is indicated for glaucoma."}
{"id":"CHEMBL1201338","canonicalSmiles":"CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1","inchiKey":"SKYSRIRYMSLOIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOPENTOLATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cyclopentolate"],"crossReferences":{"DailyMed":["cyclopentolate%20hydrochloride"],"drugbank":["DB00979"],"chEBI":["4024"]},"childChemblIds":["CHEMBL1200473"],"count":2,"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_0005758","HP_0000616","MONDO_0004892"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 2 investigational indications."}
{"id":"CHEMBL1201447","drugType":"Unknown","blackBoxWarning":false,"name":"CALFACTANT","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Infasurf","Infasurf preservative free"],"synonyms":["Aerofact","Calfactant","SF-RI 1"],"crossReferences":{"DrugCentral":["4884"],"Wikipedia":["Calfactant"]},"count":4,"approvedIndications":["EFO_1000644"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for newborn respiratory distress syndrome and has 3 investigational indications."}
{"id":"CHEMBL1201563","drugType":"Protein","blackBoxWarning":false,"name":"INTERFERON BETA-1B","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betaseron","Extavia"],"synonyms":["BAY 86-5046","BAY-86-5046","Interferon beta-1b"],"crossReferences":{"DailyMed":["interferon%20beta-1b"],"DrugCentral":["5140"],"Wikipedia":["Interferon_beta-1b"]},"count":5,"approvedIndications":["EFO_0003885"],"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["MONDO_0100116","EFO_0003885","MONDO_0100096","EFO_0000318","EFO_0000764","EFO_0003929"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for multiple sclerosis and has 4 investigational indications."}
{"id":"CHEMBL1201611","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN LISPRO PROTAMINE RECOMBINANT","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Insulin lispro protamine recombinant"],"count":2,"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0001360","EFO_0000400"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 2 investigational indications."}
{"id":"CHEMBL1201834","drugType":"Antibody","blackBoxWarning":false,"name":"CANAKINUMAB","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ilaris"],"synonyms":["ACZ-885","ACZ885","Canakinumab"],"crossReferences":{"DailyMed":["canakinumab"],"DrugCentral":["4952"],"Wikipedia":["Canakinumab"]},"count":32,"approvedIndications":["Orphanet_1451","Orphanet_309025","Orphanet_208650","EFO_0000540","Orphanet_342","EFO_0002609"],"linkedTargets":{"rows":["ENSG00000125538"],"count":1},"linkedDiseases":{"rows":["EFO_0004214","EFO_0000275","EFO_0001365","EFO_0003780","EFO_0000756","EFO_0004274","EFO_0000681","DOID_13406","MONDO_0007254","Orphanet_232","EFO_1001165","EFO_0009322","EFO_1001345","EFO_0000540","EFO_0004246","EFO_0003914","Orphanet_1451","EFO_0005531","EFO_0008518","Orphanet_309025","EFO_0002506","EFO_0007135","HP_0000999","Orphanet_342","EFO_0000685","EFO_1000906","HP_0001945","EFO_0003060","EFO_0002609","EFO_0003106","MONDO_0100096","EFO_1001999","EFO_0001359","EFO_0002517","Orphanet_208650","EFO_0000341","EFO_0001360","EFO_0004265"],"count":38},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 6 approved and 26 investigational indications."}
{"id":"CHEMBL1206","canonicalSmiles":"CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21","inchiKey":"CDOZDBSBBXSXLB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHOPROPAZINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ethopropazine","Parsidol","Profenamine"],"crossReferences":{"PubChem":["90341779"],"Wikipedia":["Profenamine"],"drugbank":["DB00392"],"chEBI":["313639"]},"childChemblIds":["CHEMBL1200970"],"count":1,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000168539"],"count":1},"linkedDiseases":{"rows":["EFO_0002508"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for parkinson's disease."}
{"id":"CHEMBL1221660","canonicalSmiles":"CCOC(=O)N1CCC(Nc2cc(Cl)ccn2)CC1","inchiKey":"YQEYLCGMINXDBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1221660","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07306"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1221702","canonicalSmiles":"C[C@H]1CN=C(N)c2sccc2O1","inchiKey":"TUOXPJFCQDMQOX-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1221702","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07003"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230023","canonicalSmiles":"CCC[C@H]1COc2ccsc2C(=N)N1","inchiKey":"JIIBOYBTIWHZFJ-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230023","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07001"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230333","canonicalSmiles":"O=C(O)CCCc1cccs1","inchiKey":"VYTXLSQVYGNWLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230333","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02434"],"chEBI":["40114"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232306","canonicalSmiles":"[2H]O[2H]","inchiKey":"XLYOFNOQVPJJNP-ZSJDYOACSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEUTERIUM OXIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1098659","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2H","Deuterium oxide"],"crossReferences":{"chEBI":["41981"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1232767","canonicalSmiles":"F","inchiKey":"KRHYYFGTRYWZRS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUORIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluoride"],"crossReferences":{"drugbank":["DB11072"],"chEBI":["29228"]},"childChemblIds":["CHEMBL1909275"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1234033","canonicalSmiles":"Nc1ncc(Cc2ccccc2)s1","inchiKey":"FJIMLXBJUVLMMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234033","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08114"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235535","canonicalSmiles":"OCc1cccnc1","inchiKey":"MVQVNTPHUGQQHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOTINYL ALCOHOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Roniacol"],"synonyms":["NU-2121","Nicotinyl Alcohol (Pyridylcarbinol)","Nicotinyl alcohol","Nicotinyl alcohol (pyridylcarbinol)","Nicotinyl alcohol tartrate","Pyridylcarbinol","Pyridylmethanol","RO 1-5155"],"crossReferences":{"PubChem":["144211156","170466803","29215333"],"drugbank":["DB04145"]},"childChemblIds":["CHEMBL1324760"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL126648","canonicalSmiles":"C#CCN(Cc1cc2c(O)nc(C)nc2cc1C)c1ccc(C(=O)N[C@@H](CCc2nnn[nH]2)C(=O)O)c(F)c1","inchiKey":"IEJSCSAMMLUINT-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PLEVITREXED","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-696259","Plevitrexed","ZD-9331","ZD9331"],"crossReferences":{"drugbank":["DB06163"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL12713","canonicalSmiles":"O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1","inchiKey":"GZKLJWGUPQBVJQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERTINDOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," Germany"," Italy"," Ireland"," Netherlands"," European Union"],"classes":["Cardiotoxicity"],"year":1998},"tradeNames":["Serlect"],"synonyms":["LU 23-174","LU-23-174","Sertindole"],"crossReferences":{"PubChem":["144206958","144206971","170465613"],"Wikipedia":["Sertindole"],"drugbank":["DB06144"],"chEBI":["9122"]},"count":5,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000147246"],"count":6},"linkedDiseases":{"rows":["MONDO_0002050","HP_0000726","EFO_0005407","EFO_0005230","EFO_0000692","EFO_0005411"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for psychosis and has 4 investigational indications. It was withdrawn in United Kingdom,  Germany,  Italy,  Ireland,  Netherlands and  European Union initially in 1998 due to Cardiotoxicity."}
{"id":"CHEMBL1301","canonicalSmiles":"N=C(N)c1ccc(/C=C/c2ccc(C(=N)N)cc2O)cc1","inchiKey":"TUESWZZJYCLFNL-DAFODLJHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYSTILBAMIDINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hydroxystilbamidine"],"crossReferences":{"PubChem":["124893257","29218047"],"Wikipedia":["Hydroxystilbamidine"],"drugbank":["DB14753"]},"childChemblIds":["CHEMBL2023895","CHEMBL1200847"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953."}
{"id":"CHEMBL1326877","canonicalSmiles":"COc1ccc(C(=O)c2ccccc2O)c(O)c1","inchiKey":"MEZZCSHVIGVWFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIOXYBENZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dioxybenzone"],"crossReferences":{"PubChem":["11112287","124882184","144203968","144208191","170465540","26748001","56463069"],"drugbank":["DB11221"],"chEBI":["34208"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1330792","canonicalSmiles":"CC(=O)Nc1cc([As](=O)(O)O)ccc1O","inchiKey":"ODFJOVXVLFUVNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETARSONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gynoplix","S.v.c.","Stovarsol"],"synonyms":["Acetarsol","Acetarsone"],"crossReferences":{"PubChem":["144204889","170466503","26665850","26748312","56424027","69767","8139955"],"Wikipedia":["Acetarsol"],"drugbank":["DB13268"]},"count":2,"approvedIndications":["DOID_10113","EFO_0005044"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for trypanosomiasis and leishmaniasis."}
{"id":"CHEMBL133463","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]1O","inchiKey":"UFZTZBNSLXELAL-IOSLPCCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756672"],"drugbank":["DB03909"],"chEBI":["40532"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1373","canonicalSmiles":"NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1","inchiKey":"YFGHCGITMMYXAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MODAFINIL","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Modafinil","Provigil"],"synonyms":["CEP 1538","CEP-1538","CRC-40476","CRL 40476","CRL-40476","DEP-1538","Modafinil","Modafinil civ","THN-102 COMPONENT MODAFINIL","THN102 COMPONENT MODAFINIL"],"crossReferences":{"DailyMed":["modafinil"],"PubChem":["144205023","170465042","26719679","26749058","26753746"],"Wikipedia":["Modafinil"],"drugbank":["DB00745"],"chEBI":["77585"]},"count":33,"approvedIndications":["EFO_0003888"],"linkedTargets":{"rows":["ENSG00000142319"],"count":1},"linkedDiseases":{"rows":["MONDO_0021107","EFO_0002610","MONDO_0002009","EFO_0000756","EFO_0000249","EFO_0005252","EFO_0003768","EFO_0008568","MONDO_0021063","EFO_0004698","EFO_0003829","HP_0100543","EFO_0000289","MONDO_0002050","EFO_0002506","EFO_0000712","EFO_0004701","HP_0012378","HP_0002015","EFO_0003877","EFO_0000692","EFO_0002617","EFO_0003888","HP_0000360","EFO_0002508","MONDO_0008170","EFO_0001358","EFO_0003060","EFO_0003885","EFO_0003890","MONDO_0002491","EFO_0000174","EFO_0005611","EFO_0003918","EFO_0003833","EFO_0005411","EFO_0007454"],"count":37},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for attention deficit hyperactivity disorder and has 32 investigational indications."}
{"id":"CHEMBL1436","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1","inchiKey":"JFPVXVDWJQMJEE-IZRZKJBUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFUROXIME","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["640/359","Cefuroxime","Cefuroximine","Kefurox","Zinacef"],"crossReferences":{"DailyMed":["cefuroxime","cefuroxime%20sodium"],"drugbank":["DB01112"],"chEBI":["3515"]},"childChemblIds":["CHEMBL2146124"],"count":6,"approvedIndications":["EFO_0000771","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for eye infection and bacterial disease and has 4 investigational indications."}
{"id":"CHEMBL1453317","canonicalSmiles":"CCN(CC)C(=O)c1cccc(C)c1","inchiKey":"MMOXZBCLCQITDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLTOLUAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["DEET","Deet","Diethyltoluamide","ENT-20218","ENT-22542","NSC-33840"],"crossReferences":{"PubChem":["144204654","144209178","144211234","170466080","17389576","26747323","26752940","56320635"],"Wikipedia":["DEET"],"drugbank":["DB11282"],"chEBI":["7071"]},"count":1,"approvedIndications":["EFO_0001067"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for parasitic infection."}
{"id":"CHEMBL146","canonicalSmiles":"Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1","inchiKey":"NLZUEZXRPGMBCV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYLATED HYDROXYTOLUENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BHT","Butylated hydroxytoluene","Butylhydroxytoluene","E-321","E321","FEMA NO. 2184","INS NO.321","INS-321","NSC-6347"],"crossReferences":{"PubChem":["11532869","144207086","144208291","144213719","170466785","17390001","26753102"],"Wikipedia":["Butylated_hydroxytoluene"],"chEBI":["34247"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1592101","drugType":"Small molecule","blackBoxWarning":false,"name":"BISMUTH SUBGALLATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bismuth subgallate"],"crossReferences":{"PubChem":["144205941","29218038"],"chEBI":["31292"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1605650","canonicalSmiles":"C[C@H]1CCC[C@@H](C)N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1","inchiKey":"LBXHRAWDUMTPSE-AOOOYVTPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1605650","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112432","855740"],"drugbank":["DB13792"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1627201","canonicalSmiles":"C[S@+]([O-])CCCCN=C=S","inchiKey":"SUVMJBTUFCVSAD-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-SULFORAPHANE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-sulforaphane"],"crossReferences":{"chEBI":["47809"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1657","canonicalSmiles":"CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1","inchiKey":"OGQICQVSFDPSEI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAZAROTENE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arazlo","Avage","Fabior","Tazorac","Zorac"],"synonyms":["AGN 190168","AGN-190168","Tazarotene"],"crossReferences":{"DailyMed":["tazarotene"],"PubChem":["144206075","170464671","174006350","50112778"],"Wikipedia":["Tazarotene"],"drugbank":["DB00799"],"chEBI":["32184"]},"count":6,"approvedIndications":["Orphanet_183469","EFO_0000676","EFO_0003894"],"linkedTargets":{"rows":["ENSG00000131759","ENSG00000077092","ENSG00000172819"],"count":3},"linkedDiseases":{"rows":["Orphanet_183469","MONDO_0021058","EFO_0009259","EFO_0002913","EFO_0000701","EFO_0000676","EFO_0003894"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL165790","canonicalSmiles":"CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1","inchiKey":"SFBODOKJTYAUCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRIFLAVONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ipriflavone"],"crossReferences":{"PubChem":["124883354","144205085","144206723","170465997","170466811","174006866","26719630","29215021","56422482","856008"],"Wikipedia":["Ipriflavone"],"drugbank":["DB13618"],"chEBI":["31719"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1658","canonicalSmiles":"C=C[C@]1(C)C[C@@H](OC(=O)CS[C@H]2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O","inchiKey":"STZYTFJPGGDRJD-NHUWBDDWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RETAPAMULIN","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aitabax","Altabax","Altargo"],"synonyms":["Retapamulin","SB-275833"],"crossReferences":{"DailyMed":["retapamulin"],"drugbank":["DB01256"]},"count":3,"approvedIndications":["EFO_1000714"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for impetigo and has 2 investigational indications."}
{"id":"CHEMBL16645","canonicalSmiles":"Cc1ccc(O)cc1","inchiKey":"IWDCLRJOBJJRNH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"p-CRESOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Methylphenol","p-cresol","para-cresol"],"crossReferences":{"PubChem":["144206791","144206995","144207600","144208313","144210349","170465495","17389093","26747378"],"Wikipedia":["P-Cresol"],"drugbank":["DB01688"],"chEBI":["17847"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1680","canonicalSmiles":"C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O","inchiKey":"DEQANNDTNATYII-OULOTJBUSA-N","drugType":"Protein","blackBoxWarning":false,"name":"OCTREOTIDE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sandostatin"],"synonyms":["Octreotide","SMS 201-995","SMS-201-995","SMS-995","SMS995"],"crossReferences":{"DailyMed":["octreotide%20acetate"],"PubChem":["50126343"],"Wikipedia":["Octreotide"],"drugbank":["DB00104"]},"childChemblIds":["CHEMBL3545066","CHEMBL1200480","CHEMBL2105834"],"count":25,"linkedTargets":{"rows":["ENSG00000162009","ENSG00000132671","ENSG00000278195","ENSG00000139874","ENSG00000180616"],"count":5},"linkedDiseases":{"rows":["EFO_0003086","HP_0002239","EFO_1001901","EFO_0000555","MONDO_0000540","EFO_0000768","EFO_0005252","MONDO_0007254","EFO_0009322","MONDO_0004565","Orphanet_739","EFO_0000544","EFO_0000182","EFO_0002626","Orphanet_2495","EFO_1000045","EFO_0000616","EFO_0002618","MONDO_0043579","MONDO_0000447","MONDO_0021058","EFO_0001074","EFO_0007331","HP_0002014","EFO_0003821","EFO_0000232","Orphanet_657","EFO_0003770","EFO_0004243","EFO_0001073","EFO_1001496","MONDO_0008315","EFO_0000311","MONDO_0002691","EFO_0001422","EFO_1000097","EFO_1000581","EFO_1001485","MONDO_0002120","EFO_1000478","Orphanet_774","EFO_0000574","EFO_0009545","EFO_1000852","MONDO_0024880","HP_0002019"],"count":46},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and has 25 investigational indications."}
{"id":"CHEMBL1697699","drugType":"Small molecule","blackBoxWarning":false,"name":"GALLIUM NITRATE HYDRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1200983","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gallium Nitrate Hydrate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697742","canonicalSmiles":"O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"FZWBNHMXJMCXLU-BLAUPYHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTRAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dextran","Dextran 40","LMWD"],"crossReferences":{"chEBI":["27649"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1697763","canonicalSmiles":"O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CO","inchiKey":"UIDWQGRXEVDFCA-XCVCLJGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFURTOINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nifurtoinol"],"crossReferences":{"drugbank":["DB13730"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743027","drugType":"Antibody","blackBoxWarning":false,"name":"GIRENTUXIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Rencarex"],"synonyms":["CA9-SCAN CG250","CG-250","CG250","Girentuximab","WX-G250"],"count":3,"linkedTargets":{"rows":["ENSG00000107159"],"count":1},"linkedDiseases":{"rows":["EFO_0000681","EFO_0000349","MONDO_0002367"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1743075","drugType":"Antibody","blackBoxWarning":false,"name":"TABALUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2127399","LY2127399","Tabalumab"],"count":5,"linkedTargets":{"rows":["ENSG00000102524"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002690","EFO_0003884","EFO_0003929","EFO_0001378"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1743261","canonicalSmiles":"CC1COC2(c3ccccc3Cl)c3cc(Cl)ccc3NC(=O)CN12","inchiKey":"ANUCDXCTICZJRH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEXAZOLAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mexazolam"],"crossReferences":{"PubChem":["170465840"],"drugbank":["DB15489"],"chEBI":["31842"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL177367","canonicalSmiles":"O=[N+]([O-])[O-].[Ag+]","inchiKey":"SQGYOTSLMSWVJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SILVER NITRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Avoca","Caustic","Silver nit caustic"],"synonyms":["NSC-135800","Silver Nitrate","Silver nitrate","Silver nitrate, toughened"],"crossReferences":{"DrugCentral":["4502"],"Wikipedia":["Silver_nitrate"],"drugbank":["DB11080"],"chEBI":["32130"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1773903","canonicalSmiles":"CC(=O)O[C@H]1CC(C)(C)C(=C=C/C(C)=C/C=C/C(C)=C/C=C(C)/C=C/C=C(\\C)C(=O)C[C@@]23O[C@]2(C)C[C@@H](O)CC3(C)C)[C@](C)(O)C1","inchiKey":"MNUMHDZZMWCBBX-JWAQYZNWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FUCOXANTHIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHEBI:5186","Fucoxanthin"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1817968","canonicalSmiles":"CC(C)(C)c1cc(C(C)(C)C)c2[nH]c(C(C)(C)C)c(C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCc3ccccc3)c2c1","inchiKey":"ZVOYWSKEBVVLGW-ZDCRTTOTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LTX-109","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ltx-109"],"crossReferences":{"drugbank":["DB12711"],"chEBI":["77752"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1819440","canonicalSmiles":"NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O","inchiKey":"MUNMIGOEDGHVLE-LGYYRGKSSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ORNIPRESSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ornipressin","Ornithine vasopressin","Orpressin","POR 8"],"crossReferences":{"drugbank":["DB13464"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL185097","canonicalSmiles":"CCCC[C@H](NC(=O)OCC1(Cc2ccc(F)cc2)CCC1)C(=O)C(=O)Nc1ccn[nH]1","inchiKey":"QTPYRNAKLBXKNP-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL185097","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01858"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1892286","canonicalSmiles":"CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](C(C)=O)[C@@]4(C)CC[C@@H]32)C1","inchiKey":"CRRKVZVYZQXICQ-RJJCNJEVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1892286","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11532887","144206911"],"drugbank":["DB14626"],"chEBI":["34930"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1897738","canonicalSmiles":"CCC(C)(Oc1ccc(C2(c3ccc(OC(C)(CC)C(=O)O)cc3)CCCCC2)cc1)C(=O)O","inchiKey":"BMOVQUBVGICXQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLINOFIBRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clinofibrate"],"crossReferences":{"PubChem":["170465771","174007296","50112707"],"drugbank":["DB09006"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908355","canonicalSmiles":"NC(=O)N1C(=O)/C(=C(\\O)c2cccs2)c2cc(Cl)ccc21","inchiKey":"LXIKEPCNDFVJKC-QXMHVHEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENIDAP","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-66,248","Tenidap"],"crossReferences":{"drugbank":["DB13481"],"chEBI":["35847"]},"childChemblIds":["CHEMBL2104833"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL195591","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.Cc1cc(CS(=O)(=O)c2ccc(N)cc2)no1","inchiKey":"CTNTUFQBOKZSPI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CO-TRIMOXAZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Co-trimoxazole","Cotrimoxazole"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1997373","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CC[Si](C)(C)C","inchiKey":"POADTFBBIXOWFJ-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COSITECAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Karenitecin"],"synonyms":["BNP-1350","BNP1350","Cositecan"],"crossReferences":{"PubChem":["530668"],"drugbank":["DB05806"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL202839","canonicalSmiles":"CC1(C)SCCN(S(=O)(=O)c2ccc(OCC#CCN)cc2)[C@H]1C(=O)NO","inchiKey":"AANXPIMDONQTQF-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL202839","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07121"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104194","canonicalSmiles":"COC(=O)CCC=C=CC[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1ccccc1","inchiKey":"PTOJVMZPWPAXER-VFJVYMGBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENPROSTIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Gardrin"],"synonyms":["Enprostil","RS-84135"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104788","canonicalSmiles":"O=C(O)c1ccccc1O.c1c[nH]cn1","inchiKey":"XCHHJFVNQPPLJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIDAZOLE SALICYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imidazole salicylate"],"crossReferences":{"drugbank":["DB13860"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104955","canonicalSmiles":"C=C1[C@H](O)CC(=C/C=C2\\CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@@H](C)CC)C[C@H]1O","inchiKey":"QSLUXQQUPXBIHH-YHSKWIAJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BECOCALCIDIOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2MBisP","Becocalcidiol","DP-006","DP006","QRX 101","QRX-101","Qrx-101"],"crossReferences":{"drugbank":["DB04891"]},"count":1,"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0000676"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106566","canonicalSmiles":"O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].[Ca+2].[Ca+2].[Ca+2]","inchiKey":"QORWJWZARLRLPR-UHFFFAOYSA-H","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM PHOSPHATE, TRIBASIC","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bone ash","Bone powder, purified","Calcium phosphate, tribasic","Durapatite","E-341(III)","FEMA NO. 3081","INS NO.341(III)","INS-341(III)","Tribasic calcium phosphate","WIN 40350","WIN-40350"],"crossReferences":{"drugbank":["DB11348"],"chEBI":["9679"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106939","canonicalSmiles":"CCCCCCNC(=N)NC(=N)N","inchiKey":"VAZJLPXFVQHDFB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POLIHEXANIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Polihexanide","Polyhexanide"],"crossReferences":{"DrugCentral":["4692"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2107214","canonicalSmiles":"CN(C(=O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I","inchiKey":"NJKDOADNQSYQEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOMEPROL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-7337","E7337","Iomeprol"],"crossReferences":{"PubChem":["144207160"],"drugbank":["DB11705"],"chEBI":["31710"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2107377","canonicalSmiles":"Br.Cc1ccc(Sc2ccccc2C2CCNCC2)cc1","inchiKey":"OJVYWXLMPZJYGV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEDATIOXETINE HYDROBROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2104986","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lu AA24530 (HBr)","Tedatioxetine hydrobromide"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107679","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.c1ccc(CCNCc2ccccc2)cc1","inchiKey":"JAQPGQYDZJZOIN-LQDWTQKMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENETHAMINE PENICILLIN","maximumClinicalTrialPhase":4,"parentId":"CHEMBL29","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Triplopen"],"synonyms":["Benethamine penicillin"],"crossReferences":{"chEBI":["52151"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2107817","canonicalSmiles":"NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)[O-].[Na+]","inchiKey":"RTCIKUMODPANKX-JBUOLDKXSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AVIBACTAM SODIUM","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1689063","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nxl-104"],"synonyms":["Avibactam sodium"],"crossReferences":{"DailyMed":["avibactam%20sodium"],"chEBI":["85982"]},"count":3,"approvedIndications":["EFO_0003103","EFO_0000544","EFO_1001141"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved indications."}
{"id":"CHEMBL2108151","drugType":"Antibody","blackBoxWarning":false,"name":"NACOLOMAB TAFENATOX","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nacolomab tafenatox"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108463","drugType":"Unknown","blackBoxWarning":false,"name":"GARLIC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Allium sativum","Allium sativum bulb","Allium sativum bulb extract","Allium sativum bulb powder","Allium sativum extract","Allium sativum powder","B1233","Garlic"],"count":4,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2108558","drugType":"Small molecule","blackBoxWarning":false,"name":"SENNA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Califig","Manevac","Sennoside b","Senokot","Senokot max strgh","Sure-lax","X-prep"],"synonyms":["B2056","Senna","Senna alexandrina","Senna alexandrina dry leaf","Senna alexandrina leaf","Senna alexandrina leaf dry extract","Senna alexandrina leaf extract","Senna alexandrina leaf powder","Senna extract","Senna glycosides","Senna leaf"],"count":2,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for constipation and has 1 investigational indication."}
{"id":"CHEMBL2108751","drugType":"Unknown","blackBoxWarning":false,"name":"PECTIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E-440","INS NO.440","INS-440","Pectin"],"count":7,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2108757","drugType":"Protein","blackBoxWarning":false,"name":"PENTETREOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DTPA-SMS","Pentetoreotide","Pentetreotide","SDZ 215-811","SDZ 215-811S","SDZ-215-811","SDZ-215-811S","SDZ-215811"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108975","drugType":"Protein","blackBoxWarning":false,"name":"ANCESTIM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ancestim","Ancestim (genetical recombination)","Stem cell factor ancestim"],"count":4,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109009","drugType":"Unknown","blackBoxWarning":false,"name":"CELLULOSE, MICROCRYSTALLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Avicel ph"],"synonyms":["Cellulose, crystalline","Cellulose, dispersible","Cellulose, microcrystalline","Crystalline cellulose","Dispersible cellulose","E460"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109204","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"NADROPARIN CALCIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CY 216","CY-216","Nadroparin","Nadroparin calcium"],"crossReferences":{"DrugCentral":["5162"]},"count":6,"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109500","drugType":"Antibody","blackBoxWarning":false,"name":"LIRILUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-KIR Antibody","BMS-986015","BMS-986015-01","BMS-98601501","IPH-2102","IPH2102","Lirilumab"],"count":10,"linkedTargets":{"rows":["ENSG00000125498","ENSG00000243772"],"count":2},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000616","EFO_0000095","EFO_0000222","EFO_0001378","EFO_0000183","EFO_0005952","EFO_0000181","EFO_0000311","MONDO_0001187"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL2109509","drugType":"Antibody","blackBoxWarning":false,"name":"HCBE-11","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HCBE-11","Hcbe-11"],"count":1,"linkedTargets":{"rows":["ENSG00000111321"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109531","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-6469","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-6469","MEDI6469","Medi-6469"],"count":6,"linkedTargets":{"rows":["ENSG00000186827"],"count":1},"linkedDiseases":{"rows":["EFO_0006859","EFO_0000196","EFO_0000574","EFO_0004142","MONDO_0007254","EFO_0002617"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109556","drugType":"Antibody","blackBoxWarning":false,"name":"MLN-2704","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MLN-2704","MLN-591DM1","Mln-2704"],"count":2,"linkedTargets":{"rows":["ENSG00000086205"],"count":1},"linkedDiseases":{"rows":["EFO_0000673","MONDO_0008315"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL227745","canonicalSmiles":"CC(=O)c1cc(F)c(Cl)cc1NCC(=O)Nc1ccccc1C(=O)O","inchiKey":"LBMZLHCAPBBOFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227745","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07085"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL231095","canonicalSmiles":"c1ccc(Nc2nc(Nc3ccccc3)n3nccc3n2)cc1","inchiKey":"LLYYAUZAGCZEKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL231095","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08340"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2336050","canonicalSmiles":"CCCCCCOc1nsnc1C1=CCCN(C)C1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"SJSVWTMVMBGIHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XANOMELINE TARTRATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL21536","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-246708 TARTRATE","LY246708 TARTRATE","Xanomeline Tartaric Acid","Xanomeline tartrate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2364574","canonicalSmiles":"C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.[Ca+2]","inchiKey":"GJPGCACMCURAKH-YQCFNCLSSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXYCYCLINE CALCIUM","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1433","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vibramycin"],"synonyms":["Doxycycline calcium"],"count":1,"linkedTargets":{"rows":["ENSG00000137745","ENSG00000196611","ENSG00000118113","ENSG00000137673"],"count":4},"linkedDiseases":{"rows":["EFO_0003102"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and has 1 investigational indication."}
{"id":"CHEMBL2364605","canonicalSmiles":"CN(C)[C@]1(c2ccccc2)CC[C@]2(CC1)OCCc1c3cc(F)ccc3[nH]c12","inchiKey":"CSMVOZKEWSOFER-RQNOJGIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEBRANOPADOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cebranopadol","GRT-6005","GRT6005"],"crossReferences":{"drugbank":["DB12830"]},"childChemblIds":["CHEMBL3325957"],"count":5,"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000125510","ENSG00000112038"],"count":4},"linkedDiseases":{"rows":["MONDO_0001583","EFO_0003890","EFO_0004616","HP_0003419","EFO_0003843"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL250450","canonicalSmiles":"O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12","inchiKey":"OVSQVDMCBVZWGM-QSOFNFLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOQUERCETIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isoquercetin","Isoquercitrin","NSC-115918","NSC-407304","Quercetin 3-o-glucopyranoside"],"crossReferences":{"PubChem":["26719900","49681636"],"drugbank":["DB12665"],"chEBI":["68352"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL26","canonicalSmiles":"CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC","inchiKey":"BGRJTUBHPOOWDU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULPIRIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dogmatyl","Dolmatil"],"synonyms":["N05AL01","RD-1403","Sulpiride"],"crossReferences":{"PubChem":["144212522","50104625"],"TG-GATEs":["115"],"Wikipedia":["Sulpiride"],"drugbank":["DB00391"],"chEBI":["32168"]},"count":5,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","HP_0000726","EFO_0005407","EFO_0005230","EFO_0005411","EFO_0000692"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for psychosis and has 4 investigational indications."}
{"id":"CHEMBL269634","canonicalSmiles":"C[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)O","inchiKey":"FAKRSMQSSFJEIM-BQBZGAKWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL269634","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02032"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL269732","canonicalSmiles":"C=CC[C@@H]1/C=C(\\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC","inchiKey":"QJJXYPPXXYFBGM-LFZNUXCKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TACROLIMUS","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prograf","Protopic","Tacrolimus"],"synonyms":["FK-506","FK506","FR-900506","Tacrolimus monohydrate"],"crossReferences":{"DailyMed":["tacrolimus"],"PubChem":["144205609","50111459"],"drugbank":["DB00864"],"chEBI":["61049"]},"childChemblIds":["CHEMBL3989887"],"count":111,"linkedTargets":{"rows":["ENSG00000088832"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_1000668","EFO_0001423","EFO_0005952","EFO_1000623","EFO_0006803","EFO_1000318","MONDO_0015760","EFO_0006344","EFO_0000339","EFO_0000096","EFO_1000956","Orphanet_3319","EFO_0003884","EFO_0007157","EFO_0000676","EFO_0004991","EFO_0008517","EFO_0000400","Orphanet_42738","EFO_0000198","MONDO_0013730","MONDO_0019465","EFO_0001642","HP_0000964","HP_0001410","EFO_0004286","EFO_1000309","EFO_1001946","EFO_0000384","MONDO_0008315","Orphanet_567","HP_0001399","EFO_0000546","EFO_0001422","MONDO_0009453","MONDO_0044889","EFO_0003032","Orphanet_79364","MONDO_0019472","EFO_0000574","EFO_0001378","EFO_1000550","Orphanet_231214","EFO_0001062","EFO_0003086","MONDO_0044903","EFO_0001365","EFO_0007183","EFO_0007451","EFO_0000255","EFO_1001413","MONDO_0016236","EFO_1000794","MONDO_0003541","EFO_0002430","EFO_0005676","EFO_1001996","MONDO_0002898","EFO_0000183","Orphanet_447","EFO_1000388","HP_0012115","EFO_0000616","EFO_1001779","MONDO_0019457","EFO_0000403","EFO_0000222","MONDO_0000870","EFO_0000319","EFO_0004198","EFO_0003818","MONDO_0019469","EFO_0004599","EFO_0003885","EFO_0003896","EFO_0004220","EFO_0000512","EFO_0006927","Orphanet_774","EFO_1001947","MONDO_0002367","MONDO_0018906","EFO_0007141","EFO_0000763","EFO_0003872","EFO_0000729","MONDO_0000873","EFO_0003777","Orphanet_183660","MONDO_0000956","EFO_1000131","Orphanet_848","EFO_0000540","EFO_0000565","EFO_0000309","EFO_0004251","MONDO_0019088","EFO_0000182","EFO_0000330","EFO_0004255","EFO_0000253","EFO_0004208","MONDO_0004768","EFO_1000785","EFO_0009441","EFO_0005761","HP_0003124","EFO_0000220","EFO_0002687","EFO_0004236","EFO_0004194","MONDO_0044881","EFO_0002429","Orphanet_811","MONDO_0019474","MONDO_0100096","EFO_0000270","EFO_0001359","MONDO_0021193","EFO_0002428","EFO_1001051","EFO_0001360","MONDO_0019471","Orphanet_232","EFO_1000965","EFO_1000764","EFO_1001020","EFO_0000274","HP_0001915","EFO_1001469","EFO_1002048","EFO_1000690","HP_0000083","Orphanet_906","EFO_0004254","EFO_0003144","EFO_1001993","EFO_0003047","EFO_0000717","EFO_0000685","EFO_0000545","EFO_0000621","EFO_0000311","MONDO_0001705","EFO_0000211","EFO_0003834","EFO_0000095","EFO_0006475","EFO_0001421","EFO_0009510","MONDO_0020077","EFO_0000691"],"count":153},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 111 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL278623","canonicalSmiles":"CC(C)(N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)NC=O","inchiKey":"UJVDJAPJQWZRFR-DHIUTWEWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MACIMORELIN","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Macrilen","Solorel"],"synonyms":["AEZS-130","ARD-07","Ard-07","EP-01572","EP-1572","EP01572","JMV 1843","JMV-1843","Macimorelin"],"crossReferences":{"DailyMed":["macimorelin%20acetate"],"drugbank":["DB13074"]},"childChemblIds":["CHEMBL2364617"],"count":1,"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["HP_0004326"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017 and has 1 investigational indication."}
{"id":"CHEMBL279676","canonicalSmiles":"c1csc(C2(N3CCCCC3)CCCCC2)c1","inchiKey":"JUZZEWSCNBCFRL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENOCYCLIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tenocyclidine"],"crossReferences":{"PubChem":["144205386","29216149"],"Wikipedia":["Tenocyclidine"],"drugbank":["DB01520"],"chEBI":["64610"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL280487","canonicalSmiles":"C=C1[C@@H]([C@@H](O)C[C@H](C)[C@H]2O[C@@]3(CCCCO3)CC[C@H]2C)O[C@@H]2CC[C@@]3(CC[C@H](/C=C/[C@@H](C)[C@@H]4CC(C)=C[C@@]5(O[C@H](C[C@@](C)(O)C(=O)O)CC[C@H]5O)O4)O3)O[C@H]2[C@@H]1O","inchiKey":"QNDVLZJODHBUFM-WFXQOWMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OKADAIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Okadaic_acid"],"drugbank":["DB02169"],"chEBI":["44658"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL280541","canonicalSmiles":"C[C@H](Sc1nc(N)cc(Cl)n1)c1cc2ccoc2cn1","inchiKey":"ATCRIOJPQXDFNY-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PNU-142721","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PNU-142721"],"crossReferences":{"drugbank":["DB08414"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL283639","canonicalSmiles":"Cc1cc(CCCCCCCOc2ccc(C3=NCCO3)cc2)on1","inchiKey":"FKLJPTJMIBLJAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DISOXARIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Disoxaril","WIN 51,711","WIN-51711"],"crossReferences":{"drugbank":["DB08726"],"chEBI":["3846"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL284483","canonicalSmiles":"OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)[C@H](O)[C@@H]1O","inchiKey":"YOOVTUPUBVHMPG-LODYRLCVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COFORMYCIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coformycin","NSC-277817"],"crossReferences":{"chEBI":["16213"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL284733","canonicalSmiles":"N#CC(c1ccc(Cl)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl","inchiKey":"ZSZFUDFOPOMEET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICLAZURIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diclazuril","R64,433"],"crossReferences":{"PubChem":["144206198","50113287"],"Wikipedia":["Diclazuril"],"drugbank":["DB11398"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL289351","canonicalSmiles":"COc1ccc(/C=C\\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"VXNQMUVMEIGUJW-XNOMRPDFSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSBRETABULIN DISODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1206232","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CA 4P","CA-4DP","CA4DP","Fosbretabulin disodium","Fosbretabulin disodium salt"],"count":4,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000123416","ENSG00000137285","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_0000616","EFO_0004683","EFO_0006859","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL290960","canonicalSmiles":"CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1","inchiKey":"ARFHIAQFJWUCFH-IZZDOVSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFURTIMOX","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lampit"],"synonyms":["BAY 2502","BAY A2502","BAY-2502","BAY-A2502","BAYER 2502","BAYER-2502","DNDI1613515","Nifurtimox"],"crossReferences":{"Wikipedia":["Nifurtimox"],"drugbank":["DB11820"],"chEBI":["7566"]},"count":6,"approvedIndications":["DOID_10113","MONDO_0001444","EFO_0005044","EFO_0008559"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 4 approved and 2 investigational indications."}
{"id":"CHEMBL295069","canonicalSmiles":"NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](OP(=O)(O)O)[C@@H]3O)[C@@H](O)[C@H]2O)c1","inchiKey":"XJLXINKUBYWONI-NNYOXOHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM beta-NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03461"],"chEBI":["44409"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL303958","canonicalSmiles":"Nc1nc(N)c(N=O)c(OCC2CCCCC2)n1","inchiKey":"DGWXOLHKVGDQLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NU-6027","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NU-6027"],"crossReferences":{"PubChem":["29217602","49674690","529470","90340579"],"drugbank":["DB08312"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL305785","canonicalSmiles":"O=C(O)C(=O)N(c1ccccc1C(=O)O)c1cccc2ccc(O)cc12","inchiKey":"IGOULVZYQKJJKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL305785","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07295"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3113974","canonicalSmiles":"CS(=O)(=O)Nc1ccc(C(=O)O[C@@H](Cc2c(Cl)c[n+]([O-])cc2Cl)c2ccc(OC(F)F)c(OCC3CC3)c2)cc1OCC1CC1","inchiKey":"VCFBPAOSTLMYIV-SANMLTNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHF-6001","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHF6001","Chf-6001","Chf6001","J3.309.618F","Tanimilast"],"crossReferences":{"drugbank":["DB12800"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3126004","canonicalSmiles":"C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O)Oc1ccccc1)C(=O)OCc1ccccc1","inchiKey":"NHTKGYOMICWFQZ-KKQYNPQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSGEMCITABINE PALABENAMIDE, P(RS)-","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acelarin","CPF-31","Fosgemcitabine palabenamide, p(rs)-","NUC-1031","Nuc-1031"],"crossReferences":{"drugbank":["DB15057"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3128043","canonicalSmiles":"Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1","inchiKey":"AYCPARAPKDAOEN-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03758309","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-03758309","PF-3758309","Pf-03758309"],"crossReferences":{"drugbank":["DB11775"]},"count":1,"linkedTargets":{"rows":["ENSG00000130669"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3188339","canonicalSmiles":"C=CC[N@@+]12CC[C@@]34c5ccccc5N5/C=C6/[C@H]7C[C@H]8[C@@]9(CC[N@@+]8(CC=C)C/C7=C/CO)c7ccccc7N(/C=C(/[C@@H](C[C@@H]31)/C(=C\\CO)C2)[C@H]54)[C@@H]69.[Cl-].[Cl-]","inchiKey":"CPYGBGOXCJJJGC-GKLGUMFISA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ALCURONIUM CHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3305985","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alloferin"],"synonyms":["Alcuronium chloride","Diallylnortoxiferene dichloride","RO 4-3816"],"crossReferences":{"PubChem":["144204127"],"chEBI":["31185"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3237191","canonicalSmiles":"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"KGWWHPZQLVVAPT-HRNDJLQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3237191","maximumClinicalTrialPhase":0,"parentId":"CHEMBL482968","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL325424","canonicalSmiles":"Cc1cccc(-c2ccc3c(c2)c(C(=O)C(=O)O)cn3Cc2ccc(C(C)(C)C)cc2)c1","inchiKey":"HSXLMAFNWCSZGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALEPLASININ","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aleplasinin","PAZ-417"],"crossReferences":{"drugbank":["DB12635"]},"count":1,"linkedTargets":{"rows":["ENSG00000106366"],"count":1},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3301583","drugType":"Unknown","blackBoxWarning":false,"name":"ANDEXANET ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Andexanet alfa","PRT-064445","PRT-4445","PRT064445","rfXa Inhibitor Antidote"],"count":1,"linkedTargets":{"rows":["ENSG00000003436"],"count":1},"linkedDiseases":{"rows":["MP_0001914","EFO_0000551"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3408248","canonicalSmiles":"C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12","inchiKey":"LMJFJIDLEAWOQJ-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3408248","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15029"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3410450","canonicalSmiles":"Cc1cn2nc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)cc2nc1N1CC[C@H](N)C1","inchiKey":"GOFXWTVKPWJNGD-UWJYYQICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRESATOVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-5806","Presatovir"],"crossReferences":{"drugbank":["DB12165"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545017","canonicalSmiles":"O=C(c1ccc(O)c(F)c1)N(c1ccc(O)cc1)c1ccc(F)cc1","inchiKey":"FBCQEUMZZNVQKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GTX-758","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Capesaris"],"synonyms":["Gtx 758","Gtx-758"],"crossReferences":{"drugbank":["DB14969"]},"count":1,"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545213","canonicalSmiles":"N#CC(c1ccnc(OCc2ccc(CN3CCOCC3)cc2)n1)c1nc2ccccc2s1","inchiKey":"XCPPIJCBCWUBNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENTAMAPIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["As-602801","Bentamapimod","PGL-5001"],"count":1,"linkedTargets":{"rows":["ENSG00000107643","ENSG00000050748","ENSG00000109339"],"count":3},"linkedDiseases":{"rows":["EFO_0001065"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545218","drugType":"Small molecule","blackBoxWarning":false,"name":"VORUCICLIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P1446a-05","Voruciclib"],"count":4,"linkedTargets":{"rows":["ENSG00000135446"],"count":1},"linkedDiseases":{"rows":["EFO_0000095","EFO_0000756","MONDO_0044881","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545245","drugType":"Small molecule","blackBoxWarning":false,"name":"BAY-1082439","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bay-1082439"],"count":1,"linkedTargets":{"rows":["ENSG00000051382","ENSG00000121879"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3585580","canonicalSmiles":"COc1ccc(Oc2cc(N(C)CCOc3ccc(CC4SC(=O)NC4=O)cc3)ncn2)cc1","inchiKey":"CHHXEZSCHQVSRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOBEGLITAZONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lobeglitazone"],"crossReferences":{"drugbank":["DB09198"]},"childChemblIds":["CHEMBL3780740"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL360563","canonicalSmiles":"CCc1cc(-c2n[nH]cc2-c2c[nH]cn2)c(O)cc1O","inchiKey":"ATORUNMAUREKMH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL360563","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03749"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3646221","canonicalSmiles":"O=C(O)CNC(=O)c1ncc(-c2cccc(Cl)c2)cc1O","inchiKey":"JGRXMPYUTJLTKT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VADADUSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AKB-6548","B-506","B506","PG-1016548","PG1016548","Vadadustat"],"crossReferences":{"drugbank":["DB12255"]},"count":2,"linkedTargets":{"rows":["ENSG00000135766","ENSG00000129521","ENSG00000269858"],"count":3},"linkedDiseases":{"rows":["EFO_0001421","EFO_0004272"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL364748","canonicalSmiles":"O=C(O)[C@H](Cc1ccccc1)Oc1ccc(Cl)cc1","inchiKey":"CPBLTMSKPQDJPW-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL364748","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08760"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL369475","canonicalSmiles":"COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314.O","inchiKey":"WRRSFOZOETZUPG-FFHNEAJVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CODEINE MONOHYDRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL485","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Codeine Monohydrate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707311","canonicalSmiles":"CCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@@]21C","inchiKey":"AJAMXPWEAPICIM-XCAPYKEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VAMOROLONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VBP-15","Vamorolone"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL371197","canonicalSmiles":"O[C@@H]1[C@H](O)CN2CCC[C@@H](O)[C@H]12","inchiKey":"FXUAIOOAOAVCGD-WCTZXXKLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIDOLGOSIR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Swainsonine","Tridolgosir"],"crossReferences":{"PubChem":["144205611","26756869","487039","50111467"],"Wikipedia":["Swainsonine"],"drugbank":["DB02034"],"chEBI":["9367"]},"childChemblIds":["CHEMBL2107226"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL371428","canonicalSmiles":"C#CCN[C@@H]1CCc2ccc(O)cc21","inchiKey":"NRSDGDXUWMMUEV-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL371428","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04307"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL372164","canonicalSmiles":"CS(=O)(=O)N1CCC([C@H]2c3ccc(Cl)cc3C(N3CCNCC3)=Cc3cccnc32)CC1","inchiKey":"ZMGCFGGMTCMSDP-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL372164","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07216"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL372795","canonicalSmiles":"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O","inchiKey":"UCSJYZPVAKXKNQ-HZYVHMACSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"STREPTOMYCIN","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chemform","Gerox","NSC-14083","Strepcen","Streptomycin"],"crossReferences":{"drugbank":["DB01082"],"chEBI":["17076"]},"childChemblIds":["CHEMBL3184791","CHEMBL453087"],"count":5,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1946 and is indicated for bacterial disease and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL373466","canonicalSmiles":"C[C@@H](Cl)CCl","inchiKey":"KNKRKFALVUDBJE-GSVOUGTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-1,2-Dichloropropane","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-1,2-Dichloropropane"],"crossReferences":{"drugbank":["DB01701"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL379692","canonicalSmiles":"COc1cc(C)c(S(=O)(=O)NC[C@@H](O)[C@@H](N)Cc2ccccc2)c(C)c1C","inchiKey":"HORGTFOBJRCVMO-ZWKOTPCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL379692","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07527"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833367","drugType":"Small molecule","blackBoxWarning":false,"name":"SATRAPLATIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-182751","BMY-45594","JM-216","Satraplatin"],"crossReferences":{"DrugCentral":["4703"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL391586","canonicalSmiles":"N#Cc1c(-c2ccccc2)cc(-c2cc(Br)ccc2O)[nH]c1=O","inchiKey":"SVSYJTYGPLVUOZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL391586","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08705"],"chEBI":["86453"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3976807","canonicalSmiles":"Cc1cc(N2C(=O)NC(=O)C2(C)C)cc(C)c1CCS(=O)(=O)N1CCC2(CC1)N=C(c1ccc(OC(F)(F)F)cc1)NC2=O","inchiKey":"LDZJFVOUPUFOHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PCO-371","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PCO371","Pco-371","Pco371"],"crossReferences":{"drugbank":["DB14946"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL398880","canonicalSmiles":"CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2","inchiKey":"JOMHSQGEWSNUKU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPOTIAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Pipotiazine"],"drugbank":["DB01621"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989514","canonicalSmiles":"CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC.Cl.O.O.O","inchiKey":"KLEAIHJJLUAXIQ-JDRGBKBRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IRINOTECAN HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL481","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Campto","Camptosar","Irinotecan hydrochloride","Onivyde"],"synonyms":["CPT-11","DQ-2805","Irinotecan hydrochloride","Irinotecan hydrochloride anhydrous","Irinotecan hydrochloride hydrate","Irinotecan hydrochloride trihydrate","Irinotecan monohydrochloride trihydrate","U-101,440E","U-101440E"],"crossReferences":{"DailyMed":["irinotecan%20hydrochloride"]},"count":87,"linkedTargets":{"rows":["ENSG00000198900"],"count":1},"linkedDiseases":{"rows":["MONDO_0003060","EFO_1000419","MONDO_0000873","EFO_0000637","EFO_0000365","MONDO_0016167","MONDO_0045056","MONDO_0000956","EFO_1000657","EFO_0000632","EFO_1001951","EFO_0000565","EFO_0000309","EFO_0006732","MONDO_0002974","MONDO_0021633","MONDO_0008903","MONDO_0005411","EFO_1000532","MONDO_0020634","EFO_0002918","EFO_1000785","EFO_0000364","MONDO_0003000","EFO_0002618","MONDO_0001852","MONDO_0002537","EFO_1000606","MONDO_0019465","EFO_1000292","MONDO_0018271","MONDO_0021321","EFO_0000248","MONDO_0008170","EFO_1001512","MONDO_0004669","EFO_0002939","EFO_0000502","MONDO_0008315","MONDO_0001879","MONDO_0002691","EFO_1000407","MONDO_0015917","EFO_1001365","MONDO_0044787","Orphanet_398934","EFO_0003032","EFO_0005537","EFO_0000574","EFO_1001051","EFO_1000550","MONDO_0019471","EFO_0002938","MONDO_0044964","MONDO_0004192","MONDO_0044887","EFO_1001465","MONDO_0007254","MONDO_0003196","EFO_1000475","EFO_0000255","EFO_1001469","MONDO_0021063","MONDO_0002087","EFO_0004252","MONDO_0044937","MONDO_0020654","MONDO_0001187","MONDO_0001056","EFO_1001480","EFO_1000044","EFO_1001013","MONDO_0002158","MONDO_0001475","EFO_0006352","MONDO_0003165","EFO_0002499","EFO_0000183","EFO_0004193","EFO_0005588","EFO_0000707","EFO_1000158","EFO_0000616","EFO_0006859","EFO_0000437","EFO_0000503","EFO_0000403","Orphanet_44890","EFO_1001042","MONDO_0007576","EFO_0000313","EFO_0002501","EFO_0007535","EFO_0004243","MONDO_0016717","MONDO_0021038","EFO_0003060","EFO_0000621","EFO_0000311","EFO_1001471","MONDO_0002120","EFO_0000095","EFO_0002517","EFO_0004142","EFO_0000702","MONDO_0002367","MONDO_0018906","MONDO_0024880","EFO_0000691","EFO_0000519","MONDO_0001325","MONDO_0044926"],"count":112},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 87 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989714","canonicalSmiles":"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.O=S(=O)(O)O","inchiKey":"SBKRTALNRRAOJP-BWSIXKJUSA-N","drugType":"Protein","blackBoxWarning":true,"name":"POLYMYXIN B SULFATE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3989738","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerosporin","Gppe pdr ster","Poly-rx","Polyfax","Polymycin b sulfate","Polymyxin b sulfate","Polytrim","Thiosporin"],"synonyms":["Polymixin b sulfate","Polymyxin b sulfate","Polymyxin b sulphate"],"crossReferences":{"DailyMed":["polymyxin%20b%20sulfate"]},"count":4,"approvedIndications":["MP_0001845","EFO_0000544"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and is indicated for inflammation and infection and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989868","canonicalSmiles":"Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1","inchiKey":"SDEAXTCZPQIFQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TUCATINIB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tukysa"],"synonyms":["ARRY-380","ONT-380","Ont-380","Tucatinib"],"crossReferences":{"DailyMed":["tucatinib"],"drugbank":["DB11652"]},"count":5,"approvedIndications":["EFO_1000294","MONDO_0007254"],"linkedTargets":{"rows":["ENSG00000141736"],"count":1},"linkedDiseases":{"rows":["EFO_1001480","EFO_1000294","EFO_0003968","EFO_0001421","MONDO_0007254","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for her2 positive breast carcinoma and breast cancer and has 3 investigational indications."}
{"id":"CHEMBL3990003","drugType":"Cell","blackBoxWarning":false,"name":"BALTALEUCEL-T","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Baltaleucel","Baltaleucel-t","CMD-003"],"count":1,"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3990047","canonicalSmiles":"CNc1ncc(-c2ccc3c(=O)c(C(=O)O)cn(C4CC4)c3c2C)cc1C","inchiKey":"XPIJWUTXQAGSLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OZENOXACIN","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xepi"],"synonyms":["GF-001001-00","Ozenoxacin","T-3912"],"crossReferences":{"DailyMed":["ozenoxacin"],"drugbank":["DB12924"]},"count":1,"approvedIndications":["EFO_1000714"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017 and is indicated for impetigo."}
{"id":"CHEMBL416898","canonicalSmiles":"Clc1ccc(C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl)cc1","inchiKey":"YVGGHNCTFXOJCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROPHENOTHANE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chlorophenothane","Chlorphenotane","Clofenotane","Ddt","Dicophane","Penticide"],"crossReferences":{"PubChem":["144204627","144208693","144210387","170465529","17389946","26747293","26752896"],"Wikipedia":["DDT"],"drugbank":["DB13424"],"chEBI":["16130"]},"count":1,"approvedIndications":["EFO_0001067"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for parasitic infection."}
{"id":"CHEMBL422","canonicalSmiles":"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1","inchiKey":"ZEWQUBUPAILYHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRIFLUOPERAZINE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amylozine","Stelazine","Stelazine fte"],"synonyms":["NSC-17474","NSC-46061","RP-7623","Trifluoperazine"],"crossReferences":{"DailyMed":["trifluoperazine%20hydrochloride"],"PubChem":["11110644","11110645","124877144","124877145","174006276","26751598","26751599","4252673","50100152","50104251","50104252","50104253","57287812","90341087","92763314"],"Wikipedia":["Trifluoperazine"],"drugbank":["DB00831"],"chEBI":["45951"]},"childChemblIds":["CHEMBL1726794","CHEMBL1257040","CHEMBL1710"],"count":1,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000102468","ENSG00000151577","ENSG00000147246"],"count":5},"linkedDiseases":{"rows":["EFO_0005407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and is indicated for psychosis. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4227721","canonicalSmiles":"CCOC(=O)O[C@@H](C)n1nnnc1-c1c(-c2ccc(C(=O)N(c3ncccc3Cl)[C@@H]3CCCNC3)cc2F)cnn1C","inchiKey":"QTBYVAZRKWOIDU-FUHWJXTLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06815345","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06815345","Pf-06815345"],"crossReferences":{"drugbank":["DB14862"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4292264","canonicalSmiles":"CC1(C)CCC2(CC1)N[C@@H](C(=O)N[C@@H]1CC[C@@H](C(N)=O)OC1)[C@H](c1ccnc(Cl)c1F)[C@]21C(=O)Nc2cc(Cl)ccc21","inchiKey":"RYAYYVTWKAOAJF-QISPRATLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MILADEMETAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DS-3032","Ds-3032","Milademetan"],"crossReferences":{"drugbank":["DB15257"]},"childChemblIds":["CHEMBL4297374"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297147","canonicalSmiles":"CC(O)C(=O)O.O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1","inchiKey":"BVUSNQJCSYDJJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HALOPERIDOL LACTATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL54","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Haldol","Haloperidol intensol","Haloperidol lactate"],"synonyms":["Haloperidol lactate"],"crossReferences":{"DailyMed":["haloperidol%20lactate"]},"count":3,"approvedIndications":["EFO_0000692"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000102468","ENSG00000151577"],"count":4},"linkedDiseases":{"rows":["EFO_0000692","EFO_0005411","HP_0000713"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for schizophrenia and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297204","canonicalSmiles":"NCCC[C@H](N)C(=O)O.O=C(O)Cc1ccccc1","inchiKey":"LRSYFEZBIMVWRY-VWMHFEHESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORNITHINE PHENYLACETATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL446143","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-OP","OCR-002","OP","Ocr-002","Ornithine phenylacetate"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297310","canonicalSmiles":"Cc1ccccc1CN1C(=O)C2=C(CCN(Cc3ccccc3)C2)N2CCN=C12","inchiKey":"VLULRUCCHYVXOH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONC-201","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-350625","ONC201","Onc 201","Onc-201","Onc201","TIC-10","TIC10"],"crossReferences":{"drugbank":["DB14844"]},"count":9,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL4297420","canonicalSmiles":"[223Ra]","inchiKey":"HCWPIIXVSYCSAN-OIOBTWANSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RADIUM RA-223","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4300465","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Radium ra-223","Radium-223"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297535","drugType":"Unknown","blackBoxWarning":false,"name":"FISH OIL TRIGLYCERIDES","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Omegaven"],"synonyms":["Fish oil triglycerides"],"crossReferences":{"DailyMed":["fish%20oil%20triglycerides"]},"count":9,"approvedIndications":["MONDO_0001751"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for cholestasis and has 8 investigational indications."}
{"id":"CHEMBL4297579","drugType":"Gene","blackBoxWarning":false,"name":"VALOCTOCOGENE ROXAPARVOVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMN-270","BMN270","Valoctocogene roxaparvovec"],"count":1,"description":"Gene drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297621","canonicalSmiles":"C[C@@H](N[C@H]1CCN(c2ccc(CC(=O)O)cc2)C1)c1cccc2ccccc12","inchiKey":"RZNUIYPHQFXBAN-XLIONFOSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EVOCALCET","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Evocalcet","KHK-7580","KHK7580","Khk7580","MT-4580"],"crossReferences":{"drugbank":["DB12388"]},"childChemblIds":["CHEMBL4128835"],"count":1,"linkedTargets":{"rows":["ENSG00000036828"],"count":1},"linkedDiseases":{"rows":["EFO_1001173","EFO_0008506"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297644","canonicalSmiles":"Cc1n[nH]cc1-c1cc2nc([C@@H]3CC4CCN3CC4)[nH]c(=O)c2s1","inchiKey":"XGVXKJKTISMIOW-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMUROSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Simurosertib","TAK-931","Tak 931","Tak-931"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297649","canonicalSmiles":"CC(C)COc1cc(F)cc(-c2ccc(C(=O)NS(=O)(=O)c3ccccc3)c(N3C[C@@H](C)CC3(C)C)n2)c1","inchiKey":"NHOUNZMCSIHKHJ-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLACAFTOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Olacaftor","VX-440","Vx-440"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297812","drugType":"Unknown","blackBoxWarning":false,"name":"PREP-001","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jnj-43260295","Prep-001"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297822","drugType":"Unknown","blackBoxWarning":false,"name":"SAN-300","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["San-300"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297826","drugType":"Unknown","blackBoxWarning":false,"name":"SGN-CD123A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SGN-CD123A","Sgn-cd123a"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297839","drugType":"Protein","blackBoxWarning":false,"name":"TIRZEPATIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-3298176","LY3298176","Ly3298176","Tirzepatide"],"count":3,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297850","drugType":"Antibody","blackBoxWarning":false,"name":"XENTUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 836845","BI-836845","Bi 836845","Xentuzumab"],"count":4,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297917","drugType":"Unknown","blackBoxWarning":false,"name":"BPN-14770","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BPN-14770","BPN14770","Bpn-14770","Bpn14770"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297944","drugType":"Unknown","blackBoxWarning":false,"name":"EDI-200","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APO200","EDI-200","EDI200","Edi-200","Edi200"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297954","drugType":"Unknown","blackBoxWarning":false,"name":"FIBROBLAST GROWTH FACTOR-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acidic fibroblast growth factor","Fgf-1","Fibroblast growth factor-1"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297966","drugType":"Antibody","blackBoxWarning":false,"name":"DEZAMIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dezamizumab","GSK-2398852","GSK2398852","Gsk2398852","anti-SAP mAb"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297973","drugType":"Unknown","blackBoxWarning":false,"name":"HEPATITIS B VIRUS HBSAG SURFACE PROTEIN ANTIGEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adsorbed hepatitis b vaccine","Hbsag","Hepatitis b vaccine","Hepatitis b vaccine (recombinant)","Hepatitis b virus hbsag surface protein antigen","Hepatitis b virus vaccine"],"count":13,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL4298099","drugType":"Unknown","blackBoxWarning":false,"name":"SAR-439459","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GC-2008","GC2008","SAR-439459","SAR439459","Sar-439459","Sar439459"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL43048","canonicalSmiles":"CNC(C)Cc1ccc2c(c1)OCO2","inchiKey":"SHXWCVYOXRDMCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIDOMAFETAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,4-Methylenedioxymethamphetamine","Mdma","Methylenedioxy Methamphetamine","Methylenedioxymethamphetamine","Midomafetamine"],"crossReferences":{"Wikipedia":["MDMA"],"drugbank":["DB01454"],"chEBI":["1391"]},"childChemblIds":["CHEMBL3189075"],"count":6,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL43068","canonicalSmiles":"CC(C)[C@H](N)C(=O)O","inchiKey":"KZSNJWFQEVHDMF-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-valine","NSC-76038","Valine"],"crossReferences":{"Wikipedia":["Valine"],"drugbank":["DB00161"],"chEBI":["16414"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL439849","canonicalSmiles":"N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1","inchiKey":"SGEGOXDYSFKCPT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VILAZODONE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["EMD 515259","EMD-515259","EMD-68-843","Vilazodone"],"crossReferences":{"DailyMed":["vilazodone%20hydrochloride"],"Wikipedia":["Vilazodone"],"drugbank":["DB06684"],"chEBI":["70707"]},"childChemblIds":["CHEMBL1615374"],"count":4,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000178394"],"count":2},"linkedDiseases":{"rows":["EFO_0007191","EFO_0001072","EFO_1001892","MONDO_0002050","MONDO_0002009","EFO_0003761","EFO_0001358","EFO_1001916"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for unipolar depression and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL440","canonicalSmiles":"C=CCC1(C(C)CCC)C(=O)N=C(S)NC1=O","inchiKey":"XLOMZPUITCYLMJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAMYLAL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Thiamylal"],"crossReferences":{"Wikipedia":["Thiamylal"],"drugbank":["DB01154"],"chEBI":["9536"]},"childChemblIds":["CHEMBL1201065"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL443114","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@H](O[C@H]3CC[C@@]4(C)C(=CC[C@H]5[C@@H]6C[C@@H]7O[C@]8(CC[C@@H](C)CN8)[C@@H](C)[C@@H]7[C@@]6(C)CC[C@@H]54)C3)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"MBWUSSKCCUMJHO-ZGXDEBHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOLAMARGINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Solamargine"],"crossReferences":{"Wikipedia":["Solamargine"],"drugbank":["DB12700"],"chEBI":["9185"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL453280","canonicalSmiles":"COc1ccc2c(=O)c(-c3ccc(O)cc3)coc2c1","inchiKey":"LNIQZRIHAMVRJA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOFORMONENTIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isoformonentin"],"crossReferences":{"drugbank":["DB04202"],"chEBI":["29608"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL456929","canonicalSmiles":"CNC(=O)CCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN(CC1CC1)S(=O)(=O)c1ccco1","inchiKey":"IKOPFHKAECNGQI-VQTJNVASSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL456929","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08223"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594250","canonicalSmiles":"Cc1ccc(C(=O)OCc2ccc([C@@H](CN)C(=O)Nc3ccc4cnccc4c3)cc2)c(C)c1","inchiKey":"OURRXQUGYQRVML-AREMUKBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NETARSUDIL","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AR-11324 FREE BASE","AR-13324","Netarsudil"],"crossReferences":{"DailyMed":["netarsudil%20dimesylate","netarsudil%20mesylate"]},"childChemblIds":["CHEMBL4594251"],"count":3,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000134318","ENSG00000067900"],"count":2},"linkedDiseases":{"rows":["Orphanet_98974","EFO_0004190","EFO_1001069","EFO_1000879","EFO_0000516"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for glaucoma and has 2 investigational indications."}
{"id":"CHEMBL4594262","canonicalSmiles":"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl.O=C(O)c1ccccc1","inchiKey":"RVPCEXXEUXIPEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMLODIPINE BENZOATE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1491","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Katerzia"],"synonyms":["Amlodipine benzoate"],"crossReferences":{"DailyMed":["amlodipine%20benzoate"]},"count":1,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019 and is indicated for hypertension."}
{"id":"CHEMBL4594558","drugType":"Antibody","blackBoxWarning":false,"name":"RAGIFILIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INCAGN-01876","INCAGN01876","Incagn01876","Ragifilimab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594581","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN 287","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Insulin 287","NNC0148-0287","Nnc0148-0287"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL463","canonicalSmiles":"Nc1ccc(C(=O)NCC(=O)O)cc1","inchiKey":"HSMNQINEKMPTIC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOHIPPURIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aminohippuric Acid","Aminohippuric acid","NSC-13064","P-aminohippuric acid","Paha","Para-aminohippuric acid"],"crossReferences":{"PubChem":["11112164","124882008","144203896","170465155","26748682","56463545"],"Wikipedia":["Aminohippuric_acid"],"drugbank":["DB00345"],"chEBI":["104011"]},"childChemblIds":["CHEMBL1200365"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL46469","canonicalSmiles":"O=C1c2c(O)cccc2Cc2cccc(O)c21","inchiKey":"NUZWLKWWNNJHPT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTHRALIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alphodith","Anthra-derm","Antraderm","Dithrocream","Dithrocream fte","Dithrocream hp","Drithocreme","Drithoscalp","Lasan","Micanol","Psoradrate","Psorin","Psorin fte","Stie-lasan"],"synonyms":["Anthralin","Dithranol","NSC-43970","NSC-629313"],"crossReferences":{"PubChem":["144204666","144209049","144210610","170466655","17389175","26747336","57260153","98251"],"Wikipedia":["Dithranol"],"drugbank":["DB11157"],"chEBI":["37510"]},"count":1,"approvedIndications":["EFO_0000676"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for psoriasis."}
{"id":"CHEMBL466269","canonicalSmiles":"CC(=O)N1c2cccc(O)c2NC2=C(C(=O)CC(C)(C)C2)[C@@H]1c1ccc(Cl)cc1Cl","inchiKey":"JJTPPGUNMJMPLY-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL466269","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08747"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL467058","canonicalSmiles":"CCCCCCCC(=O)OC[C@@H](O)[C@@H](OC)[C@@H]1OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]1NC(C)=O","inchiKey":"UKTIJASCFRNWCB-RMIBSVFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANINAMIVIR OCTANOATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS-8958","Laninamivir octanoate","Laninamivir octanoic acid ester","R-118958"],"crossReferences":{"drugbank":["DB11888"]},"childChemblIds":["CHEMBL2093880"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL48449","canonicalSmiles":"C[C@]12C(=O)OC(=O)[C@@]1(C)[C@@H]1CC[C@H]2O1","inchiKey":"DHZBEENLJMYSHQ-XCVPVQRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANTHARIDIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cantharidin","NSC-61805"],"crossReferences":{"PubChem":["109184","11112131"],"Wikipedia":["Cantharidin"],"drugbank":["DB12328"],"chEBI":["64213"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL485835","canonicalSmiles":"C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(CCOCc3cc(F)cc(F)c3)[C@@H](O)CC[C@@H]12","inchiKey":"AJODXHGZHBERGJ-JLYQOUBASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL485835","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07717"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL489679","canonicalSmiles":"C[C@H]1CN(Cc2ccc(CC(=O)N3CCC(Nc4cccc(F)c4)CC3)cc2)CCN1.Cl","inchiKey":"MZEVMNJFEUATKJ-FYZYNONXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL489679","maximumClinicalTrialPhase":0,"parentId":"CHEMBL489095","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL490","canonicalSmiles":"Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1","inchiKey":"AHOUBRCZNHFOSL-YOEHRIQHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PAROXETINE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paxil [as hydrochloride]"],"synonyms":["BRL 29060","BRL-29060","Paroxetine","Paxil","Pexeva"],"crossReferences":{"DailyMed":["paroxetine%20hydrochloride","paroxetine%20mesylate"],"PubChem":["144206674","170465075","26752262","29215051","50104978","50104979","50104980","50104981","90341371"],"Wikipedia":["Paroxetine"],"drugbank":["DB00715"],"chEBI":["7936"]},"childChemblIds":["CHEMBL1708","CHEMBL1449490","CHEMBL1200609","CHEMBL1256912","CHEMBL3133300","CHEMBL1628650"],"count":19,"approvedIndications":["MONDO_0002050","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["EFO_0004320","EFO_0005687","EFO_0004262","MONDO_0002009","EFO_0000555","HP_0000726","EFO_1001917","HP_0031217","EFO_0003829","EFO_0000289","MONDO_0002050","EFO_0003761","EFO_0004242","EFO_0005230","EFO_0000692","EFO_1001872","EFO_0005762","HP_0000360","EFO_0002508","EFO_0001645","EFO_0000677","EFO_1001908","EFO_0001358","MONDO_0002775","EFO_1001892","EFO_0004220","EFO_0007948","EFO_0000612","EFO_0003918","EFO_0003922"],"count":30},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for depressive disorder and unipolar depression and has 17 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL5","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21","inchiKey":"MHWLWQUZZRMNGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALIDIXIC ACID","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mictral","Nalidixic acid","Nalix","Neg Gram","Neggram","Negram","Uriben","Uroneg","Wintomylon"],"synonyms":["NSC-82174","Nalidixane","Nalidixic acid","WIN 18,320","WIN-18320"],"crossReferences":{"PubChem":["120913","124883418","144204386","144208675","144213071","170465215","17389812","174006246","26746931","26751459","26751460","56422386","855620","90340622"],"Wikipedia":["Nalidixic_acid"],"drugbank":["DB00779"],"chEBI":["100147"]},"childChemblIds":["CHEMBL1741367","CHEMBL1255939"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL507674","canonicalSmiles":"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O","inchiKey":"GCFBRXLSHGKWDP-XCGNWRKASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOPERAZONE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefoperazone"],"crossReferences":{"Wikipedia":["Cefoperazone"],"drugbank":["DB01329"],"chEBI":["3493"]},"childChemblIds":["CHEMBL1551899","CHEMBL1200482","CHEMBL1697715"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL508461","canonicalSmiles":"O=C(O)C[C@@H](NC(=O)c1cc(-c2ccc(-c3ccncc3)cc2)cs1)c1ccccc1","inchiKey":"VMTJQZUZINLEKC-JOCHJYFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL508461","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03367"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL512351","canonicalSmiles":"COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1","inchiKey":"XHOLNRLADUSQLD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BETRIXABAN","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bevyxxa"],"synonyms":["Betrixaban","PRT-054021","PRT054021"],"crossReferences":{"DailyMed":["betrixaban"],"Wikipedia":["Betrixaban"],"drugbank":["DB12364"]},"count":8,"approvedIndications":["EFO_0004286","HP_0004419"],"linkedTargets":{"rows":["ENSG00000126218"],"count":1},"linkedDiseases":{"rows":["HP_0001907","EFO_0003911","MP_0001914","EFO_0003086","EFO_0000275","EFO_0001421","EFO_0004286","HP_0004419"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for recurrent thrombophlebitis and venous thromboembolism and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL532","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O","inchiKey":"ULGZDMOVFRHVEP-RWJQBGPGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHROMYCIN","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["A/t/s","Akne-mycin","Aknemycin plus","C-solve-2","E-base","E-glades","E-mycin","E-solve 2","Emgel","Ery-tab","Eryacne 2","Eryacne 4","Eryc","Eryc 125","Eryc sprinkles","Erycette","Eryderm","Erygel","Erymax","Erymax sprinkle","Erythra-derm","Erythro 200","Erythro-statin","Erythrocin","Erythromycin","Gallimycin","Ilotycin","Isotrexin","Kerymax","Oftalmolosa cusi eritromicina","Paediathrocin","R-p mycin","Retcin","Robimycin","Rommix 250 ec","Rommix 500 ec","Sansac","Staticin","Stiemycin","T-stat","Tiloryth","Wyamycin","Zineryt"],"synonyms":["Benzamycin","Bristamycin","E-Base","E-Glades","E-Mycin","ERY-TAB","Erypar","Erythro-Statin","Erythrocin","Erythromycin","Erythromycin estolate impurity, free erythromycin-","J01FA01","NSC-55929","PCE","Pfizer-E"],"crossReferences":{"DailyMed":["erythromycin","erythromycin%20stearate"],"DrugCentral":["3875"],"PubChem":["144204864","144205422","144210833","49675035"],"Wikipedia":["Erythromycin"],"drugbank":["DB00199"],"chEBI":["42355"]},"childChemblIds":["CHEMBL1200506","CHEMBL1200476","CHEMBL1200510","CHEMBL3545060","CHEMBL3786307"],"count":20,"approvedIndications":["EFO_0000771","EFO_1001888","EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 3 approved and 17 investigational indications."}
{"id":"CHEMBL539640","canonicalSmiles":"NCc1ccc(-c2cccs2)cc1","inchiKey":"YKNLMMDEWQZCLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL539640","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07259"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL539906","canonicalSmiles":"O=c1[nH]cnc2sc3c(c12)CCCC3","inchiKey":"NMMOEJUJKIXUQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL539906","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4255332"],"drugbank":["DB08777"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL54126","canonicalSmiles":"CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-]","inchiKey":"LULNWZDBKTWDGK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"NEOSTIGMINE BROMIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL278020","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Neostigmine","Neostigmine bromide"],"crossReferences":{"PubChem":["144205590","170465765","26747582","50106653","56423116","855599"],"Wikipedia":["Neostigmine"],"chEBI":["179557"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL55483","canonicalSmiles":"Cc1cc(CCCCCCCOc2ccc(C3=N[C@H](C)CO3)cc2)on1","inchiKey":"NEAZMARKCJKUMF-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL55483","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08727"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL560511","canonicalSmiles":"CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5","inchiKey":"RMRJXGBAOAMLHD-IHFGGWKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Buprenorphine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Buprenorphine"],"crossReferences":{"drugbank":["DB00921"],"chEBI":["3216"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL563377","canonicalSmiles":"COc1ccc(/N=c2/[nH]c(N)c(C(=O)c3ccc(OC)cc3)s2)cc1","inchiKey":"XQKUGFIWKSKCDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL563377","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49668017","530855"],"drugbank":["DB07488"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL574060","canonicalSmiles":"O=C1c2c(O)cccc2C(=O)c2c([N+](=O)[O-])ccc(O)c21","inchiKey":"RIYCICFDXLNQPV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL574060","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03035"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL602070","canonicalSmiles":"CC1=C(C(=O)N2CCC[C@H]2c2ccc(F)cc2)[C@@H](c2ccc(Cl)c(Cl)c2)n2nccc2N1","inchiKey":"LADJRPDOKVCQCG-NZQKXSOJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-394136","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-394136"],"crossReferences":{"drugbank":["DB12067"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL607710","canonicalSmiles":"NC(=O)OCC(O)COc1ccc(Cl)cc1","inchiKey":"SKPLBLUECSEIFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPHENESIN CARBAMATE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maolate"],"synonyms":["Chlorphenesin","Chlorphenesin carbamate","U-19,646","U-19646"],"crossReferences":{"PubChem":["144204038","56463366"],"Wikipedia":["Chlorphenesin"],"drugbank":["DB14656"],"chEBI":["3643"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1965."}
{"id":"CHEMBL66552","canonicalSmiles":"CC(C(=O)[O-])c1ccc(CC2CCCC2=O)cc1.[Na+]","inchiKey":"WORCCYVLMMTGFR-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"LOXOPROFEN SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL19299","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Loxoprofen Sodium"],"crossReferences":{"PubChem":["49681557"],"chEBI":["76198"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL786","canonicalSmiles":"CC/C(=C(\\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"FQZYTYWMLGAPFJ-OQKDUQJOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TAMOXIFEN CITRATE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL83","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emblon","Fentamox 10","Fentamox 20","Kentadex","Kessar","Kessar 10","Kessar 20","Noltam","Nolvadex","Nolvadex d","Nolvadex fte","Oestrifen-10","Oestrifen-20","Oestrifen-40","Soltamox","Tamofen","Tamoxifen citrate","Zynoplex"],"synonyms":["I.C.I.46474 CITRATE","ICI 46,474","ICI-46474","Tamoxifen citrate"],"crossReferences":{"DailyMed":["tamoxifen%20citrate"],"PubChem":["11112087","11112088","124881893","144204489","144209268","144210594","170465425","17389724","26747686","26747687","26747688","26752019","447264","49816809","50107133","85231332"],"chEBI":["9397"]},"count":43,"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_1000403","EFO_0000637","EFO_0001075","EFO_1001901","MONDO_0007254","MONDO_0002087","EFO_0000305","HP_0000771","EFO_1000984","MONDO_0001187","MONDO_0002158","EFO_0000289","EFO_1001375","EFO_0000389","EFO_0006890","EFO_1000251","EFO_0000326","EFO_0000253","MONDO_0004647","EFO_1000158","EFO_0001416","EFO_0000616","MONDO_0007608","Orphanet_145","EFO_0000545","MONDO_0004658","MONDO_0008170","EFO_1001512","EFO_0000232","EFO_0003843","EFO_0000660","MONDO_0008315","EFO_0000311","EFO_0000537","EFO_0000294","MONDO_0002691","MP_0001914","EFO_0000304","EFO_0004220","EFO_0009708","Orphanet_98896","MONDO_0100096","Orphanet_398934","EFO_0006861","EFO_0000764","MONDO_0011962","Orphanet_774","EFO_0000432","MONDO_0024880","EFO_0000519","EFO_0003922"],"count":52},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 43 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL78794","canonicalSmiles":"O=C(O)C(C(=O)O)c1ccccc1","inchiKey":"WWYDYZMNFQIYPT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Phenyl-Malonic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Phenyl-Malonic Acid"],"crossReferences":{"drugbank":["DB04080"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL80","canonicalSmiles":"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5","inchiKey":"UZHSEJADLWPNLE-GRGSLBFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALOXONE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nalone","Narcan","Narcanti"],"synonyms":["NSC-70413","Naloxone","Suboxone"],"crossReferences":{"DailyMed":["naloxone%20hydrochloride"],"PubChem":["144205559","170465008"],"Wikipedia":["Naloxone"],"drugbank":["DB01183"],"chEBI":["7459"]},"childChemblIds":["CHEMBL3186613","CHEMBL1718","CHEMBL1512507"],"count":26,"approvedIndications":["HP_0002019"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0004240","MONDO_0001583","HP_0000989","EFO_0000555","MONDO_0004567","MONDO_0004565","MONDO_0018555","EFO_0003913","EFO_0000474","EFO_0002506","HP_0003419","EFO_0003047","EFO_1000785","EFO_0005762","EFO_0005203","HP_0012532","EFO_0005612","EFO_0002508","EFO_0010702","EFO_0001073","EFO_0003843","EFO_0000311","EFO_0003890","EFO_0005800","EFO_0009842","EFO_0001359","EFO_1001051","EFO_0005611","EFO_0004699","EFO_0004270","HP_0002019"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for constipation and has 25 investigational indications."}
{"id":"CHEMBL8290","canonicalSmiles":"O=C([O-])[C@H]1/C(=C/CO)O[C@@H]2CC(=O)N21.[Na+]","inchiKey":"WOGMLDNCNBLDCA-JSYANWSFSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CLAVULANIC ACID (SODIUM)","maximumClinicalTrialPhase":0,"parentId":"CHEMBL777","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL85799","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@H](O)CC[C@]34C)[C@@H]1CCC2=O","inchiKey":"QGXBDMJGAMFCBF-BNSUEQOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIOCHOLANOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etiocholanolone","Etiocholanone"],"crossReferences":{"PubChem":["56323424","85148331"],"Wikipedia":["Etiocholanolone"],"drugbank":["DB02854"],"chEBI":["28195"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL90555","canonicalSmiles":"CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1","inchiKey":"OGWKCGZFUXNPDA-XQKSVPLYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VINCRISTINE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Vincristine"],"crossReferences":{"PubChem":["124892473","144205620","170465186"],"chEBI":["28445"]},"childChemblIds":["CHEMBL501867"],"count":56,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0000637","EFO_0004708","EFO_0000558","EFO_0000756","EFO_1000131","EFO_0005952","EFO_1001951","EFO_0000565","EFO_0000309","EFO_0007160","MONDO_0015760","EFO_0000588","EFO_0000096","HP_0001871","MONDO_0002974","MONDO_0019088","MONDO_0008903","MONDO_0015540","EFO_0002918","EFO_0000094","Orphanet_654","EFO_0009441","EFO_0000198","EFO_1000292","EFO_0000220","MONDO_0018271","EFO_0000248","EFO_0000180","EFO_0002939","Orphanet_636","EFO_1001946","EFO_0000502","EFO_0009708","EFO_1001365","EFO_0003032","MONDO_0044889","MONDO_0044917","EFO_0000574","EFO_0001378","MONDO_0015564","MONDO_0009348","MONDO_0019471","EFO_0000255","Orphanet_790","MONDO_0016236","EFO_0000209","EFO_1001469","MONDO_0004095","MONDO_0003541","MONDO_0016700","EFO_0000272","EFO_0004289","MONDO_0001657","EFO_1001830","EFO_0002499","EFO_0000183","MONDO_0020743","EFO_0010580","MONDO_0002083","MONDO_0002618","EFO_1000635","MONDO_0003478","EFO_1000158","EFO_0000616","EFO_0000765","EFO_1000616","EFO_0006859","EFO_0000437","Orphanet_59305","EFO_0000403","Orphanet_1063","EFO_1001042","MONDO_0000870","EFO_0000313","EFO_0000222","MONDO_0016717","EFO_0000621","EFO_0000311","EFO_0000211","EFO_0000095","EFO_0000174","EFO_0005235","EFO_1001936","EFO_1002008","EFO_1001947","MONDO_0002367","EFO_0000702","MONDO_0018906","MONDO_0019004","EFO_0003833","EFO_0000691","MONDO_0021637","EFO_0000519"],"count":94},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and is indicated for neoplasm and has 55 investigational indications. This drug has a black box warning from the FDA."}
